Nursing and immunization for immunodepressed patients related to malignant neoplasia
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , , , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Research, Society and Development |
Texto Completo: | https://rsdjournal.org/index.php/rsd/article/view/11516 |
Resumo: | Introduction: Immunization is a measure of prevention and control for certain diseases, and under normal conditions, the cells of the human body are able to respond to numerous infectious or antigenic stimuli, in addition to vaccination. Objective: to describe the particular aspects of immunization in patients undergoing cancer treatment. Methodology: Integrative review study. The analysis was carried out after applying the inclusion and exclusion criteria, and a database was built covering the items title, year of publication, periodical, CAPES qualis, study design, scenarios and country. Results: 24 articles were analyzed, 58.3% without qualification classification, and in the others, frequency of qualifications in A2 (60.0%). The study design concentrated 54.1% at level 02 of scientific evidence. The vaccines described in the studies were a total of 11, with emphasis on Influenza with an occurrence of 83.3%. For seroconversion, the positive result was 31.9% (15/47). Final Considerations: It is concluded that the productions are concentrated in a high level of scientific evidence, denoting experiments for the application of attenuated vaccines in patients immunocompromised by malignant neoplasms. |
id |
UNIFEI_96041b6ff742fc5d73bc6b11e831e1b6 |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/11516 |
network_acronym_str |
UNIFEI |
network_name_str |
Research, Society and Development |
repository_id_str |
|
spelling |
Nursing and immunization for immunodepressed patients related to malignant neoplasiaEnfermería e inmunización para pacientes inmunodeprimidos relacionados con neoplasia malignaEnfermagem e imunização aos pacientes imunodeprimidos relacionados à neoplasia malignaImunizaçãoNeoplasiaQuimioterapiaEnfermagemSaúde pública.InmunizaciónNeoplasiaQuimioterapiaEnfermeríaSalud pública.ImmunizationNeoplasiaChemotherapyNursingPublic health.Introduction: Immunization is a measure of prevention and control for certain diseases, and under normal conditions, the cells of the human body are able to respond to numerous infectious or antigenic stimuli, in addition to vaccination. Objective: to describe the particular aspects of immunization in patients undergoing cancer treatment. Methodology: Integrative review study. The analysis was carried out after applying the inclusion and exclusion criteria, and a database was built covering the items title, year of publication, periodical, CAPES qualis, study design, scenarios and country. Results: 24 articles were analyzed, 58.3% without qualification classification, and in the others, frequency of qualifications in A2 (60.0%). The study design concentrated 54.1% at level 02 of scientific evidence. The vaccines described in the studies were a total of 11, with emphasis on Influenza with an occurrence of 83.3%. For seroconversion, the positive result was 31.9% (15/47). Final Considerations: It is concluded that the productions are concentrated in a high level of scientific evidence, denoting experiments for the application of attenuated vaccines in patients immunocompromised by malignant neoplasms.Introducción: La inmunización es una medida de prevención y control de determinadas enfermedades y, en condiciones normales, las células del cuerpo humano son capaces de responder a numerosos estímulos infecciosos o antigénicos, además de la vacunación. Objetivo: describir los aspectos particulares de la inmunización en pacientes sometidos a tratamiento oncológico. Metodología: Estudio de revisión integradora. El análisis se realizó luego de aplicar los criterios de inclusión y exclusión, y se construyó una base de datos con el título de los ítems, año de publicación, revista, calificación CAPES, diseño del estudio, escenarios y país. Resultados: se analizaron 24 artículos, 58,3% sin clasificación de calificación, y en los demás, frecuencia de calificaciones en A2 (60,0%). El diseño del estudio concentró el 54,1% en el nivel 02 de evidencia científica. Las vacunas descritas en los estudios fueron un total de 11, con énfasis en Influenza con una ocurrencia del 83,3%. Para la seroconversión, el resultado positivo fue del 31,9% (15/47). Consideraciones finales: Se concluye que las producciones se concentran en un alto nivel de evidencia científica, denotando experimentos para la aplicación de vacunas atenuadas en pacientes inmunodeprimidos por neoplasias malignas.Introdução: A imunização é uma medida de prevenção e controle para determinadas doenças, e em condições normais, as células do corpo humano são capazes de responder a inúmeros estímulos infecciosos ou antigénicos, além da vacinação. Objetivo: descrever os aspectos particulares da imunização em pacientes em tratamento oncológico. Metodologia: Estudo do tipo revisão integrativa. A análise foi realizada após aplicação dos critérios de inclusão e exclusão, e construído um banco de dados contemplando os itens título, ano de publicação, periódico, qualis CAPES, delineamento do estudo, cenários e país. Resultados: Foram 24 artigos analisados, 58,3% sem classificação de qualis, e nos demais, frequência de qualis em A2 (60,0%). O delineamento do estudo concentrou 54,1% no nível 02 de evidência científica. As vacinas descritas nos estudos foram em um total de 11, com destaque para a Influenza com ocorrência de 83,3%. Para a soroconversão, o resultado positivo apresentou-se em 31,9% (15/47). Considerações Finais: Conclui-se que as produções são concentradas em alto nível de evidência científica, denotando experimentos para aplicação de vacinas atenuadas em pacientes imunocomprometidos por neoplasia maligna.Research, Society and Development2021-01-04info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/1151610.33448/rsd-v10i1.11516Research, Society and Development; Vol. 10 No. 1; e10210111516Research, Society and Development; Vol. 10 Núm. 1; e10210111516Research, Society and Development; v. 10 n. 1; e102101115162525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/11516/10303Copyright (c) 2021 Mary Hellem Silva Fonseca; Mercedes Neto; Eliza Aguiar de Almeida; Ricardo de Mattos Russo Rafael; Sonia Acioli de Oliveira; Fernando Portohttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessFonseca, Mary Hellem Silva Neto, MercedesAlmeida, Eliza Aguiar de Rafael, Ricardo de Mattos Russo Oliveira, Sonia Acioli de Porto, Fernando2021-02-20T21:19:23Zoai:ojs.pkp.sfu.ca:article/11516Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:33:19.251964Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false |
dc.title.none.fl_str_mv |
Nursing and immunization for immunodepressed patients related to malignant neoplasia Enfermería e inmunización para pacientes inmunodeprimidos relacionados con neoplasia maligna Enfermagem e imunização aos pacientes imunodeprimidos relacionados à neoplasia maligna |
title |
Nursing and immunization for immunodepressed patients related to malignant neoplasia |
spellingShingle |
Nursing and immunization for immunodepressed patients related to malignant neoplasia Fonseca, Mary Hellem Silva Imunização Neoplasia Quimioterapia Enfermagem Saúde pública. Inmunización Neoplasia Quimioterapia Enfermería Salud pública. Immunization Neoplasia Chemotherapy Nursing Public health. |
title_short |
Nursing and immunization for immunodepressed patients related to malignant neoplasia |
title_full |
Nursing and immunization for immunodepressed patients related to malignant neoplasia |
title_fullStr |
Nursing and immunization for immunodepressed patients related to malignant neoplasia |
title_full_unstemmed |
Nursing and immunization for immunodepressed patients related to malignant neoplasia |
title_sort |
Nursing and immunization for immunodepressed patients related to malignant neoplasia |
author |
Fonseca, Mary Hellem Silva |
author_facet |
Fonseca, Mary Hellem Silva Neto, Mercedes Almeida, Eliza Aguiar de Rafael, Ricardo de Mattos Russo Oliveira, Sonia Acioli de Porto, Fernando |
author_role |
author |
author2 |
Neto, Mercedes Almeida, Eliza Aguiar de Rafael, Ricardo de Mattos Russo Oliveira, Sonia Acioli de Porto, Fernando |
author2_role |
author author author author author |
dc.contributor.author.fl_str_mv |
Fonseca, Mary Hellem Silva Neto, Mercedes Almeida, Eliza Aguiar de Rafael, Ricardo de Mattos Russo Oliveira, Sonia Acioli de Porto, Fernando |
dc.subject.por.fl_str_mv |
Imunização Neoplasia Quimioterapia Enfermagem Saúde pública. Inmunización Neoplasia Quimioterapia Enfermería Salud pública. Immunization Neoplasia Chemotherapy Nursing Public health. |
topic |
Imunização Neoplasia Quimioterapia Enfermagem Saúde pública. Inmunización Neoplasia Quimioterapia Enfermería Salud pública. Immunization Neoplasia Chemotherapy Nursing Public health. |
description |
Introduction: Immunization is a measure of prevention and control for certain diseases, and under normal conditions, the cells of the human body are able to respond to numerous infectious or antigenic stimuli, in addition to vaccination. Objective: to describe the particular aspects of immunization in patients undergoing cancer treatment. Methodology: Integrative review study. The analysis was carried out after applying the inclusion and exclusion criteria, and a database was built covering the items title, year of publication, periodical, CAPES qualis, study design, scenarios and country. Results: 24 articles were analyzed, 58.3% without qualification classification, and in the others, frequency of qualifications in A2 (60.0%). The study design concentrated 54.1% at level 02 of scientific evidence. The vaccines described in the studies were a total of 11, with emphasis on Influenza with an occurrence of 83.3%. For seroconversion, the positive result was 31.9% (15/47). Final Considerations: It is concluded that the productions are concentrated in a high level of scientific evidence, denoting experiments for the application of attenuated vaccines in patients immunocompromised by malignant neoplasms. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-01-04 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/11516 10.33448/rsd-v10i1.11516 |
url |
https://rsdjournal.org/index.php/rsd/article/view/11516 |
identifier_str_mv |
10.33448/rsd-v10i1.11516 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/11516/10303 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Research, Society and Development |
publisher.none.fl_str_mv |
Research, Society and Development |
dc.source.none.fl_str_mv |
Research, Society and Development; Vol. 10 No. 1; e10210111516 Research, Society and Development; Vol. 10 Núm. 1; e10210111516 Research, Society and Development; v. 10 n. 1; e10210111516 2525-3409 reponame:Research, Society and Development instname:Universidade Federal de Itajubá (UNIFEI) instacron:UNIFEI |
instname_str |
Universidade Federal de Itajubá (UNIFEI) |
instacron_str |
UNIFEI |
institution |
UNIFEI |
reponame_str |
Research, Society and Development |
collection |
Research, Society and Development |
repository.name.fl_str_mv |
Research, Society and Development - Universidade Federal de Itajubá (UNIFEI) |
repository.mail.fl_str_mv |
rsd.articles@gmail.com |
_version_ |
1797052667901509632 |